Obstruction
Also known as: Obstruction (morphologic abnormality) / Obstruction NOS
Drug | Drug Name | Drug Description |
---|---|---|
DB00085 | Pancrelipase | A purified form of porcine pancreatic lipase, amylase, and protease enzymes used to treat malabsorption associated with pancreatic insufficiency resulting from cystic fibrosis and pancreatitis. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00085 | Pancrelipase | Dietary fat | target |
DB00085 | Pancrelipase | Dietary protein | target |
DB00085 | Pancrelipase | Dietary starch | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09422 | Soybean oil | 4 | Completed | 1 |
DB14776 | Camrelizumab | Not Available | Recruiting | 1 |